AstraZeneca invests $70 million to expand Nijmegen facility

23 september 2025
Nijmegen, 8 September 2025 – AstraZeneca is expanding its production site in Nijmegen with a $70 million investment. The expansion, officially launched with a groundbreaking ceremony led by Mayor Hubert Bruls, will add a second filling line and create around 30 new jobs (growing from 100 to 130 employees).

The Nijmegen site plays a key role in filling, inspecting, and distributing biological medicines, ranging from cancer treatments to vaccines for premature babies.

According to AstraZeneca, the expansion not only strengthens its manufacturing capabilities but also reinforces the Netherlands’ position as a Life Sciences & Health hub. Oost NL, the NFIA, the Province of Gelderland, and the City of Nijmegen supported the project, assisting with permits, grid capacity challenges, and financing options.

The site is also known for its sustainability ambitions and follows AstraZeneca’s Ambition Zero Carbon program, which aims for net zero emissions by 2045. Nijmegen has already taken a leading role, achieving a 99% reduction in greenhouse gas emissions (compared to 2015) and transitioning to a fully electric vehicle fleet.

Bron: www.oostnl.nl